Autoantibodies to vascular smooth muscle are pathogenic for vasculitis

American Journal of Pathology

Volumn 166, Issue 6, 2005, Pages 1851-1860

  Baiu, Dana Carina ^a   Barger, Brittany ^a   Sandor, Matyas ^a   Fabry, Zsuzsa ^a   Hart, Michael Noel ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD23 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M ANTIBODY; RAG2 PROTEIN; SMOOTH MUSCLE ANTIBODY; SYNDECAN 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BLAST CELL; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VASCULAR SMOOTH MUSCLE; VASCULITIS; WILD TYPE;

EID: 19544369142     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62494-7     Document Type: Article

References (47)

1. Jayne D: Evidence-based treatment of systemic vasculitis. Rheumatology 2000, 39:585-595
2. Katz P: Vasculitis. Samter's Immunologic Diseases, ed 6. Edited by Austen KF, Frank MM, Atkinson JP, Cantor H. Baltimore, Lippincott Williams and Wilkins, 2001, pp 560-570
3. Morahan G, Morel L: Genetics of autoimmune diseases in humans and in animal models. Curr Opin Immunol 2002, 14:803-811
4. Specks U: Are animal models of vasculitis suitable tools. Curr Opin Rheumatol 2000, 12:11-19
5. Hart MN, Waldschmidt MM, Hanley-Hyde JM, Moore SA, Kemp JD, Schelper RL: Brain microvascular smooth muscle expresses class II antigens. J Immunol 1987, 138:2960-2963
6. Fabry Z, Sandor M, Gajewski TF, Herlein JA, Waldschmidt MM, Lynch RG, Hart MN: Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. J Immunol 1993, 151:38-47
7. Fabry Z, Fitzsimmons KM, Herlein JA, Moninger TO, Dobbs MB, Hart MN: Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol 1993, 47:23-34
8. Hart MN, Fabry Z, Waldschmidt M, Sandor M: Lymphocyte interacting adhesion molecules on brain microvascular cells. Mol Immunol 1990, 27:1355-1359
9. Hart MN, Tassell SK, Sadewasser KL, Schelper RL, Moore SA: Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. Am J Pathol 1985, 119:448-455
10. Swanson BJ, Baiu DC, Sandor M, Fabry Z, Hart MN: A small population of vasculitogenic T cells expands and has skewed T cell receptor usage after culture with syngeneic smooth muscle cells. J Autoimmun 2003, 20:125-133
11. Fabry Z, Waldschmidt MM, Van Dyk L, Moore SA, Hart MN: Activation of CD4+ lymphocytes by syngeneic brain microvascular smooth muscle cells. J Immunol 1990, 145:1099-1104
12. Savage CO, Harper L, Holland M: New findings in pathogenesis of anti-neutrophil cytoplasm antibody-associated vasculitis. Curr Opin Rheumatol 2002, 14:15-22
13. Beliveau A, Dagenais P, Menard HA: Finding a valid model for antineutrophil cytoplasmic antibody-related vasculitis. Arthritis Rheum 1997, 40:986-987
14. Bordron A, Revelen R, D'Arbonneau F, Dueymes M, Renaudineau Y, Jamin C, Youinou P: Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 2001, 124:492-501
15. Grunebaum E, Blank M, Cohen S, Afek A, Kopolovic J, Meroni PL, Youinou P, Shoenfeld Y: The role of anti-endothelial cell antibodies in Kawasaki disease-in vitro and in vivo studies. Clin Exp Immunol 2002, 130:233-240
16. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH, Lee S, Bang D: Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 2003, 48:2025-2035
17. Cunningham MW, Meissner HC, Heuser JS, Pietra BA, Kurahara DK, Leung DY: Anti-human cardiac myosin autoantibodies in Kawasaki syndrome. J Immunol 1999, 163:1060-1065
18. Suzuki H, Muragaki Y, Uemura S, Takeuchi T, Minami T, Shibuta S, Ohshima A, Yoshikawa N: Detection of auto-antibodies against a 70 kDa protein derived from vascular smooth muscle cells in patients with Kawasaki disease. Eur J Pediatr 2002, 161:324-329
19. Damianovich M, Gilburd B, George J, Del Papa N, Afek A, Goldberg I, Kopolovic Y, Roth D, Barkai G, Meroni PL, Shoenfeld Y: Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996, 156:4946-4951
20. Bordron A, Dueymes M, Levy Y, Jamin C, Ziporen L, Piette JC, Shoenfeld Y, Youinou P: Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum 1998, 41:1738-1747
21. Krause I, Blank M, Shoenfeld Y: The induction of experimental vascular diseases by immunization with pathogenic autoantibodies. Clin Exp Rheumatol 2000, 18:257-261
22. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110:955-963
23. Moore SA, Strauch AR, Yoder EJ, Rubenstein PA, Hart MN: Cerebral microvascular smooth muscle in tissue culture. In Vitro 1984, 20:512-520
24. Tomer Y, Barak V, Gilburd B, Shoenfeld Y: Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. Clin Exp Rheumatol 1999, 17:521-526
25. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D: From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999, 10:451-461
26. Janeway Jr CA, Carding S, Jones B, Murray J, Portoles P, Rasmussen R, Rojo J, Saizawa K, West J, Bottomly K: CD4+ T cells: specificity and function. Immunol Rev 1988, 101:39-80
27. Calame KL, Lin KI, Tunyaplin C: Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003, 21:205-230
28. Sze DM, Toellner KM, Garcia de Vinuesa C, Taylor DR, MacLennan IC: Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med 2000, 192:813-821
29. Ferry H, Jones M, Vaux DJ, Roberts IS, Cornall RJ: The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J Exp Med 2003, 198:1415-1425
30. Quintana FJ, Cohen IR: Autoantibody patterns in diabetes-prone NOD mice and in standard C57BL/6 mice. J Autoimmun 2001, 17:191-197
31. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330
32. Utz PJ, Gensler TJ, Anderson P: Death, autoantigen modifications, and tolerance. Arthritis Res 2000, 2:101-114
33. Rauova L, Gilburd B, Zurgil N, Blank M, Guegas LL, Brickman CM, Cebecauer L, Deutsch M, Wiik A, Shoenfeld Y: Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes. Clin Immunol 2002, 103:69-78
34. Hart MN, Sadewasser KL, Cancilla PA, DeBault LE: Experimental autoimmune type of vasculitis resulting from activation of mouse lymphocytes to cultured endothelium. Lab Invest 1983, 48:419-427
35. Wuttge DM, Eriksson P, Sirsjo A, Hansson GK, Stemme S: Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol 2001, 159:417-423
36. Ueda Y, Nagasawa K, Tsukamoto H, Horiuchi T, Nishizaka H, Ikeda K, Niho Y: Production of the third and fourth component of complement (C3, C4) by smooth muscle cells. Immunology 1996, 89:183-188
37. Mongini PKA, Vilenski MA, Highet P, Inman JK: The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon coligation of the antigen receptor with CD21 (CR2). J Immunol 1997, 159:3782-3791
38. Baiu DC, Prechl J, Tchorbanov A, Molina HD, Erdei A, Sulica A, Capel PJ, Hazenbos WL: Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J Immunol 1999, 162:3125-3130
39. Lin RH, Mamula MJ, Hardin JA, Janeway Jr CA: Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1991, 173:1433-1439
40. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ: A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999, 189:1639-1648
41. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, van Lent PL, Hofhuis FM, van Ojik HH, Sedlik C, da Silveira SA, Gerber J, de Jong YF, Roozendaal R, Aarden LA, van den Berg WB, Saito T, Mosser D, Amigorena S, Izui S, van Ommen GJ, van Vugt M, van de Winkel JG, Verbeek JS: Fcγ RI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002, 16:391-402
42. Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daeron M, van de Winkel JG, Verbeek JS: Impaired IgG-dependent anaphylaxis and Arthus reaction in Fcγ RIII (CD16) deficient mice. Immunity 1996, 5:181-188
43. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D: Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168
44. Amigorena S, Lankar D, Briken V, Gapin L: Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens. J Exp Med 1998, 187:505-515
45. Ackerman AL, Kyritsis C, Tampe R, Cresswell P: Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat Immunol 2005, 6:107-113
46. Pendergraft III WF, Preston GA, Shah RR, Tropsha A, Carter Jr CW, Jennette JC, Falk RJ: Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10:72-79
47. Shoenfeld Y: The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies. Nat Med 2004, 10:17-18